Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

179,653 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-Arm, Prospective Study.
Jiang K, Hong R, Xia W, Lu Q, Li L, Huang J, Shi Y, Yuan Z, Zheng Q, An X, Xue C, Huang J, Bi X, Chen M, Zhang J, Xu F, Wang S. Jiang K, et al. Among authors: zhang j. Cancer Res Treat. 2024 Apr;56(2):513-521. doi: 10.4143/crt.2023.786. Epub 2023 Oct 12. Cancer Res Treat. 2024. PMID: 37846468 Free PMC article.
Administration of Lapatinib with Food Increases Its Plasma Concentration in Chinese Patients with Metastatic Breast Cancer: A Prospective Phase II Study.
Xu F, Lee K, Xia W, Liao H, Lu Q, Zhang J, Yuan H, Zhang K, Zheng Q, Qin G, Zhai Q, Hong R, Jiang K, Li Y, Wang S. Xu F, et al. Among authors: zhang j, zhang k. Oncologist. 2020 Sep;25(9):e1286-e1291. doi: 10.1634/theoncologist.2020-0044. Epub 2020 Feb 14. Oncologist. 2020. PMID: 32058619 Free PMC article. Clinical Trial.
Metronomic Capecitabine Plus Aromatase Inhibitor as Initial Therapy in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer-The Phase III MECCA Trial.
Hong RX, Xu F, Xia W, Teng YE, Ouyang QC, Zheng QF, Yuan ZY, Chen DS, Jiang KK, Lin Y, Dai Z, Liu XL, Chen QJ, Wu XH, Shi YX, Huang JJ, An X, Xue C, Bi XW, Chen MT, Li H, Yao HR, Zou GR, Huang H, Zhang JM, Wang SS. Hong RX, et al. J Clin Oncol. 2025 Jan 2:JCO2400938. doi: 10.1200/JCO.24.00938. Online ahead of print. J Clin Oncol. 2025. PMID: 39746176
179,653 results
You have reached the last available page of results. Please see the User Guide for more information.